Topic

Florida

A collection of 418 issues

How to Get Evkeeza (Evinacumab) Covered by Humana in Florida: Appeals, Forms & Timeline Guide

Quick Answer: Getting Evkeeza Covered by Humana in Florida Evkeeza (evinacumab) requires prior authorization from Humana Medicare Advantage plans in Florida. Submit clinical documentation confirming homozygous familial hypercholesterolemia (HoFH) diagnosis, prior therapy failures, and current lipid levels. If denied, you have 65 days to appeal with additional evidence. For urgent
5 min read

Lowering Out-of-Pocket Costs for Pyrukynd (Mitapivat) with UnitedHealthcare in Florida: Complete Coverage and Savings Guide

Answer Box: Getting Pyrukynd Covered by UnitedHealthcare in Florida Pyrukynd (mitapivat) requires prior authorization from UnitedHealthcare and must be filled through OptumRx specialty pharmacies. Your hematologist must document genetic confirmation of pyruvate kinase deficiency (≥2 PKLR variants with ≥1 missense mutation) plus clinical severity criteria. The drug typically costs 20-30%
5 min read

How to Get Tysabri (Natalizumab) Covered by Cigna in Florida: Prior Authorization, Appeals, and State Protections

Answer Box: Get Tysabri Covered by Cigna in Florida Cigna requires prior authorization for Tysabri (natalizumab) with strict TOUCH program enrollment and medical necessity documentation. In Florida, you have enhanced protections including step therapy exemptions and external review rights. First step: Ensure your prescriber, infusion site, pharmacy, and you are
5 min read

How to Get Xenpozyme (olipudase alfa-rpcp) Covered by Aetna (CVS Health) in Florida: Complete Appeals Guide with Templates

Answer Box: Getting Xenpozyme Covered by Aetna (CVS Health) in Florida Xenpozyme (olipudase alfa-rpcp) requires prior authorization from Aetna (CVS Health) with strict criteria: confirmed ASMD diagnosis via genetic testing or enzyme assay, specialist involvement, and CVS Specialty Pharmacy dispensing. Fastest approval path: 1) Ensure genetic/enzyme confirmation is documented,
5 min read